U.S. Army Captain Michael Kelvington, commander of the Battle company, 1-508 Parachute Infantry battalion, 4th Brigade Combat Team, 82nd Airborne Division, bows next to remains of Gulam Dostager, a member of Afghan Local Police who was killed in the blast of an Improvised Explosive Device (IED) during the joint Tor Janda (Black Flag in Pashtu) operation, in Zahri district of Kandahar province, southern Afghanistan May 25, 2012.  REUTERS/Shamil Zhumatov  (AFGHANISTAN - Tags: MILITARY CIVIL UNREST CONFLICT TPX IMAGES OF THE DAY)

Reuters Photojournalism

Our day's top images, in-depth photo essays and offbeat slices of life. See the best of Reuters photography.  See more | Photo caption 

Members of the U.S. Navy Blue Angels fly over the World Trade Center in lower Manhattan as part of the 25th annual Fleet Week celebration in New York, May 23, 2012.  REUTERS/Eduardo Munoz (UNITED STATES - Tags: MILITARY ANNIVERSARY TPX IMAGES OF THE DAY)

Fleet Week

The U.S. Navy takes Manhattan for a week.  Slideshow 

Photo

The SpaceX mission

A privately owned unmanned rocket blasts off on a mission to be the first commercial flight to the International Space Station.  Slideshow 

Boston Scientific unit charged over defibrillators

Related Topics

WASHINGTON | Thu Feb 25, 2010 1:01pm EST

WASHINGTON (Reuters) - A Boston Scientific Corp subsidiary was charged with failing to report safety problems with some of its implantable defibrillators to the Food and Drug Administration, the U.S. Department of Justice said on Thursday.

It said a formal guilty plea agreement was expected to be filed in federal court later. The charges, filed in Minnesota, involved medical device manufacturer Guidant LLC.

The Justice Department said Boston Scientific had previously announced in November that it would pay $296 million on behalf of Guidant in connection with the charges.

(Reporting by James Vicini, Editing by Maureen Bavdek)

Related Quotes and News

Company
Price
Related News
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.